{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T21:10:46Z","timestamp":1768770646042,"version":"3.49.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T00:00:00Z","timestamp":1407888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0104521","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T22:13:07Z","timestamp":1407967987000},"page":"e104521","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Statin Therapy Is Associated with Improved Survival in Patients with Non-Serous-Papillary Epithelial Ovarian Cancer: A Retrospective Cohort Analysis"],"prefix":"10.1371","volume":"9","author":[{"given":"Mohammed","family":"Habis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Wroblewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bradaric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Diane","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lacey","family":"Litchfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris L.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,8,13]]},"reference":[{"key":"ref1","first-page":"1","article-title":"Deaths: Leading causes for 2010","volume":"62","author":"M Heron","year":"2013","journal-title":"Natl Vital Stat Rep"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: Systematic review and meta-analysis","volume":"326","author":"MR Law","year":"2003","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1001\/jama.2013.281348","article-title":"Statin therapy for primary prevention of cardiovascular disease","volume":"310","author":"FC Taylor","year":"2013","journal-title":"JAMA"},{"key":"ref4","unstructured":"Stone NJ, Robinson J, Lichtenstein AH, Merz CN, Blum CB, et al.. (2013) 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation: 1\u201384."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0140-6736(13)62348-X","article-title":"Statins, risk assessment, and the new American prevention guidelines","volume":"383","author":"DM Lloyd-Jones","year":"2013","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.amjmed.2007.12.011","article-title":"Statins and cancer risk","volume":"121","author":"I Karp","year":"2008","journal-title":"Am J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1200\/JCO.2004.02.027","article-title":"The risk of cancer in users of statins","volume":"22","author":"MR Graaf","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin use and reduced cancer-related mortality","volume":"367","author":"SF Nielsen","year":"2012","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1186\/1471-2407-12-487","article-title":"Statin use and association with colorectal cancer survival and risk: Case control study with prescription data linkage","volume":"12","author":"F Lakha","year":"2012","journal-title":"BMC Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1056\/NEJMoa043792","article-title":"Statins and the risk of colorectal cancer","volume":"352","author":"JN Poynter","year":"2005","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s10620-009-0790-8","article-title":"For patients with colorectal cancer, the long-term use of statins is associated with better clinical outcomes","volume":"54","author":"AA Siddiqui","year":"2009","journal-title":"Dig Dis Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0895-4356(02)00614-5","article-title":"Statin use and the risk of breast cancer","volume":"56","author":"P Beck","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djj188","article-title":"Statin use and breast cancer: Prospective results from the Women&apos;s Health Initiative","volume":"98","author":"JA Cauley","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000341977","article-title":"Association between statin usage and prostate cancer prevention: A refined meta-analysis based on literature from the years 2005\u20132010","volume":"90","author":"Y Zhang","year":"2013","journal-title":"Urol Int"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e46691","DOI":"10.1371\/journal.pone.0046691","article-title":"Statin use and risk of prostate cancer: A meta-analysis of observational studies","volume":"7","author":"D Bansal","year":"2012","journal-title":"PLOS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-2275(20)42221-7","article-title":"Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth","volume":"21","author":"MS Brown","year":"1980","journal-title":"J Lipid Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1016\/S0021-9258(18)50610-4","article-title":"Inhibition of cholesterol synthesis with compactin renders growth of cultured cells dependent on the low density lipoprotein receptor","volume":"254","author":"JL Goldstein","year":"1979","journal-title":"J Biol Chem"},{"key":"ref18","first-page":"119","article-title":"The role of cholesterol metabolism and cholesterol transport in carcinogenesis: A review of scientific findings, relevant to future cancer therapeutics","volume":"4","author":"PM Cruz","year":"2013","journal-title":"Front Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1172\/JCI0216421","article-title":"Isoprenoids as mediators of the biological effects of statins","volume":"110","author":"JK Liao","year":"2002","journal-title":"J Clin Invest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e25460","DOI":"10.4161\/cib.25460","article-title":"Small GTPases as regulators of cell division","volume":"6","author":"R Militello","year":"2013","journal-title":"Commun Integr Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijdevneu.2012.06.002","article-title":"Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line","volume":"30","author":"A Marcuzzi","year":"2012","journal-title":"Int J Dev Neurosci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1349-7006.2008.00977.x","article-title":"Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer","volume":"99","author":"A Horiuchi","year":"2008","journal-title":"Cancer Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ygyno.2013.02.003","article-title":"Preclinical evaluation of statins as a treatment for ovarian cancer","volume":"129","author":"E Robinson","year":"2013","journal-title":"Gynecol Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study","volume":"21","author":"RF Ozols","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ygyno.2008.06.007","article-title":"Impact of statin therapy on survival in epithelial ovarian cancer","volume":"111","author":"RG Elmore","year":"2008","journal-title":"Gynecol Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00280-008-0830-7","article-title":"Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression","volume":"63","author":"H Liu","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2407-10-103","article-title":"Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: Potential therapeutic relevance","volume":"10","author":"A Martirosyan","year":"2010","journal-title":"BMC Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/0008-5472.CAN-06-1147","article-title":"C-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion","volume":"67","author":"K Sawada","year":"2007","journal-title":"Cancer Research"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2008.08.013","article-title":"Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer","volume":"111","author":"M Terplan","year":"2008","journal-title":"Gynecologic Oncology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/anae.12120","article-title":"Understanding immortal time bias in observational cohort studies","volume":"68","author":"AM Ho","year":"2013","journal-title":"Anaesthesia"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: Example using statins for preventing progression of diabetes","volume":"340","author":"LE Levesque","year":"2010","journal-title":"BMJ"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/jnci\/djh081","article-title":"Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer)","volume":"96","author":"GJS Rustin","year":"2008","journal-title":"Journal of the National Cancer Institute"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/AOG.0b013e3182393ab3","article-title":"Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity","volume":"119","author":"IL Romero","year":"2012","journal-title":"Obstetrics & Gynecology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/cncr.27706","article-title":"Metformin intake is associated with better survival in ovarian cancer: A case-control study","volume":"119","author":"S Kumar","year":"2013","journal-title":"Cancer"},{"key":"ref35","first-page":"3602","article-title":"Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin","volume":"51","author":"K Keyomarsi","year":"1991","journal-title":"Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ygyno.2011.08.026","article-title":"The effects of 17\u03b2-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis","volume":"124","author":"IL Romero","year":"2012","journal-title":"Gynecologic Oncology"},{"key":"ref37","first-page":"891","article-title":"Enhanced c- erb B-2\/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A","volume":"53","author":"D Yu","year":"1992","journal-title":"Cancer Research"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0006-2952(86)90221-2","article-title":"Adriamycin accumulation and metabolism in adriamycin-sensitive and -resistant human ovarian cancer cell lines","volume":"35","author":"KG Louie","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"ref39","first-page":"5181","article-title":"Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin","volume":"51","author":"DHM Lau","year":"1991","journal-title":"Cancer Research"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/gyno.1996.0014","article-title":"p53 gene mutation analysis and antisense-mediated growth inhibition of human ovarian carcinoma cell lines","volume":"60","author":"JS Skilling","year":"1996","journal-title":"Gynecol Oncol"},{"key":"ref41","first-page":"52","article-title":"Biological properties of two newly established cell lines (RMUG-S, RMUG-L) from a human ovarian mucinous cystadenocarcinoma","volume":"3","author":"M Sakayori","year":"1990","journal-title":"Human Cell"},{"key":"ref42","first-page":"1747","article-title":"Establishment of a cell line from human ovarian cancer (undifferentiated carcinoma of FIGO classification) and analysis of its cell-biological characteristics and sensitivity to anticancer drugs","volume":"38","author":"N Yoshiya","year":"1986","journal-title":"Nihon Sanka Fujinka Gakkai Zasshi"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/onc.2013.321","article-title":"Epithelial ovarian cancer experimental models","volume":"33","author":"E Lengyel","year":"2014","journal-title":"Oncogene"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"S Domcke","year":"2013","journal-title":"Nature Communications"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"E Lengyel","year":"2010","journal-title":"American Journal of Pathology"},{"key":"ref46","first-page":"719","article-title":"Rethinking ovarian cancer: Recommendations for improving outcomes","volume":"11","author":"S Vaughan","year":"2011","journal-title":"Nature Reviews"},{"key":"ref47","first-page":"1180","article-title":"Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase","volume":"14","author":"S Kato","year":"2010","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1309\/HW2MYB5TVF4AM0Y4","article-title":"Hypercholesterolemia impairs angiogenesis in patients with breast carcinoma and, therefore, lowers the risk of metastases","volume":"122","author":"BH Ozdemir","year":"2004","journal-title":"American Journal of Clinical Pathology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ygyno.2009.09.027","article-title":"Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers","volume":"116","author":"AJ Li","year":"2010","journal-title":"Gynecologic Oncology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ygyno.2013.05.025","article-title":"The effect of statins on risk and survival of gynecological malignancies","volume":"130","author":"O Lavie","year":"2013","journal-title":"Gynecol Oncol"},{"key":"ref51","unstructured":"ClinicalTrials.gov website National Institutes of Health. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\/\" xlink:type=\"simple\">http:\/\/clinicaltrials.gov\/<\/ext-link>. Accessed 2014 April."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0104521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T12:09:04Z","timestamp":1649938144000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0104521"}},"subtitle":[],"editor":[{"given":"Shannon M.","family":"Hawkins","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,13]]},"references-count":51,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0104521","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,13]]}}}